Continuous Bioprocessing Market is Expected to Reach $599 million | MarketsandMarkets.
December 05, 2023 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Continuous Bioprocessing market in terms of revenue was estimated to be worth $218 million in 2023 and is poised to reach $599 million by 2028, growing at...
United States Regenerative Medicine Market Report 2023: Competition, Forecasts and Opportunities, 2018-2028
November 28, 2023 09:53 ET
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "United States Regenerative Medicine Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
Biopharmaceuticals Market Size to Surpass USD 799.76 Billion by 2030, at a CAGR of 7.9%
November 27, 2023 07:13 ET
|
Fortune Business Insights
Pune, India, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The global biopharmaceuticals market size was USD 437.12 billion in 2022, and it is anticipated to expand from USD 470.80 billion in 2023 to USD 799.76...
United States Wound Biologics Market Insights 2023-2028: with Avita Medical, Organogenesis, Smith+Nephew, Vericel, and Orthofix Dominating
November 22, 2023 10:18 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "US Wound Biologics Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. US wound biologics market was...
Global Antibody Collaboration and Licensing Agreement Analysis Report 2023 with Directory of 1,812 Deals Signed Since 2016
November 17, 2023 06:43 ET
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Antibody Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
Global Regenerative Medicine Partnering Deal Terms and Agreements Analysis Report 2023 with Directory of 1,700+ Deals Singed Since 2016
November 07, 2023 05:03 ET
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.com's offering. The Global...
MacroGenics to Participate in Upcoming Investor Conferences
November 02, 2023 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Nov. 02, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV)
November 02, 2023 08:30 ET
|
PaxMedica, Inc.
TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, has...
MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call
October 31, 2023 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Oct. 31, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Master the Art of Emotional Intelligence in Pharmaceuticals - A One-Day Training Course (February 12, 2024)
October 31, 2023 09:58 ET
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Training Course" conference has been added to ...